Skip to main content
. 2021 May 5;13:3639–3650. doi: 10.2147/CMAR.S254671

Figure 6.

Figure 6

Effects of inhibiting the AKT/p38 MAPK signaling pathway on NSCLC cells. (A), Effects of MK2206 on the AKT/p38 MAPK signaling pathway in NSCLC cells. (B), Comparison of cell survival rate. (C), Comparison of cell invasion ability. (D), Comparison of cell apoptosis rate. (E), The expression of apoptosis-related proteins in NSCLC cells. *Indicates P<0.05; #indicates P<0.05.